New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Launched by UNIVERSITY HOSPITAL, GRENOBLE · Jun 27, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring pelvic pain in transgender individuals who are using testosterone therapy. The goal is to understand the nature of this pain and how it affects daily life. By talking with participants, researchers want to learn about their experiences, including what helps them seek medical help and what might prevent them from doing so.
To be eligible for this study, participants must be trans masculine individuals who are taking hormone therapy to affirm their gender, live near Grenoble, and have experienced pelvic pain that started or changed after beginning this therapy. Participants can expect to share their personal experiences in interviews, which will help improve understanding and care for others in similar situations. This study is currently recruiting participants, and all genders are welcome to apply.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being a trans masculine individual
- • Taking a gender affirming hormonal therapy (GAHT)
- • living close to Grenoble
- • having pelvic pain that appeared or were modified after taking GAHT
- Exclusion Criteria:
- • Subject under guardianship or subject deprived of liberty Refusal of voice recording
About University Hospital, Grenoble
The University Hospital of Grenoble is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent sponsor of clinical trials, the hospital leverages its expertise in various medical disciplines to facilitate cutting-edge studies that aim to improve treatment outcomes and enhance patient safety. With a strong commitment to collaboration, the University Hospital of Grenoble engages in partnerships with academic institutions, industry leaders, and regulatory bodies to drive scientific discovery and translate research findings into clinical practice. Its state-of-the-art facilities and multidisciplinary teams ensure rigorous adherence to ethical standards and regulatory guidelines, fostering an environment where groundbreaking research can thrive.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Martin D'hères, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported